Tocqueville Asset Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | – | Sell |
-1,462
| Closed | -$98K | – | 981 |
|
|
2015
Q3 | $98K | Sell |
1,462
-8,897
| -86% | -$596K | ﹤0.01% | 926 |
|
|
2015
Q2 | $1.01M | Sell |
10,359
-826
| -7% | -$80.4K | 0.01% | 571 |
|
|
2015
Q1 | $1.05M | Sell |
11,185
-254
| -2% | -$23.7K | 0.01% | 576 |
|
|
2014
Q4 | $1.02M | Buy |
11,439
+3,813
| +50% | +$339K | 0.01% | 576 |
|
|
2014
Q3 | $527K | Sell |
7,626
-6,050
| -44% | -$418K | 0.01% | 606 |
|
|
2014
Q2 | $784K | Buy |
13,676
+5,796
| +74% | +$332K | 0.01% | 626 |
|
|
2014
Q1 | $312K | Buy |
7,880
+3,431
| +77% | +$136K | ﹤0.01% | 691 |
|
|
2013
Q4 | $187K | Buy |
+4,449
| New | +$187K | ﹤0.01% | 816 |
|
|
2013
Q3 | – | Sell |
-6,298
| Closed | -$334K | – | 967 |
|
|
2013
Q2 | $334K | Buy |
+6,298
| New | +$334K | ﹤0.01% | 747 |
|